{"id":"https://openalex.org/W7095077336","doi":null,"title":"Simar preet Kaur et al /J. Pharm. Sci. & Res. Vol.3(5), 2011,1227-1232 Preparation and Characterization of Rivastigmine Loaded Chitosan","display_name":"Simar preet Kaur et al /J. Pharm. Sci. & Res. Vol.3(5), 2011,1227-1232 Preparation and Characterization of Rivastigmine Loaded Chitosan","publication_year":2012,"publication_date":"2012-05-19","ids":{"openalex":"https://openalex.org/W7095077336"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.227.8835","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.227.8835","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.jpsr.pharmainfo.in/Documents/Volumes/Vol3Issue05/jpsr%2003110502.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Simar Preet Kaur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simar Preet Kaur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Rekha Rao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rekha Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Afzal Hussain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Afzal Hussain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047163043","display_name":"Sarita Khatkar","orcid":"https://orcid.org/0000-0002-6861-3589","observed_orcids":["https://orcid.org/0000-0002-6861-3589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarita Khatkar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42604827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":1.0},{"id":"https://openalex.org/keywords/chitosan-nanoparticles","display_name":"chitosan nanoparticles","score":0.9909999966621399},{"id":"https://openalex.org/keywords/chitosan-tripolyphosphate","display_name":"chitosan-tripolyphosphate","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ionic-gelation","display_name":"ionic gelation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.972000002861023},{"id":"https://openalex.org/keywords/nanoparticle-characterization","display_name":"nanoparticle characterization","score":0.7459999918937683},{"id":"https://openalex.org/keywords/drug-delivery-systems","display_name":"drug delivery systems","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C2779732960","wikidata":"https://www.wikidata.org/wiki/Q408510","display_name":"Chitosan","level":2,"score":0.7516000270843506},{"id":"https://openalex.org/C39519442","wikidata":"https://www.wikidata.org/wiki/Q904893","display_name":"Differential scanning calorimetry","level":2,"score":0.604200005531311},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5954999923706055},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.5875999927520752},{"id":"https://openalex.org/C11432220","wikidata":"https://www.wikidata.org/wiki/Q1975334","display_name":"Dispersity","level":2,"score":0.5519999861717224},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.5284000039100647},{"id":"https://openalex.org/C26771246","wikidata":"https://www.wikidata.org/wiki/Q321095","display_name":"Scanning electron microscope","level":2,"score":0.46320000290870667},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4462999999523163},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.4165000021457672},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.37299999594688416},{"id":"https://openalex.org/C146088050","wikidata":"https://www.wikidata.org/wiki/Q744818","display_name":"Transmission electron microscopy","level":2,"score":0.32030001282691956},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.31290000677108765},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.29159998893737793},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.28700000047683716},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.2791000008583069},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.27230000495910645},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.26600000262260437}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.227.8835","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.227.8835","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.jpsr.pharmainfo.in/Documents/Volumes/Vol3Issue05/jpsr%2003110502.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3146893288","https://openalex.org/W3217081232","https://openalex.org/W1983876118","https://openalex.org/W2014202811","https://openalex.org/W7204220636","https://openalex.org/W7204107278","https://openalex.org/W2034996283","https://openalex.org/W2583093292","https://openalex.org/W4281677994","https://openalex.org/W2024268060"],"abstract_inverted_index":{"Nanotechnology":[0],"mediated":[1],"drug":[2,10,106,125,174],"delivery":[3,196],"has":[4],"been":[5],"reported":[6],"to":[7,25,38],"enhance":[8],"the":[9,21,34,173,184],"efficacy,":[11],"bioavailability,":[12],"reduce":[13],"toxicity":[14],"and":[15,23,40,83,100,109,142,151,156],"improve":[16],"patient":[17],"compliance":[18],"by":[19,67,91,147],"targeting":[20],"cells":[22],"tissues":[24],"produce":[26],"desired":[27],"pharmacological":[28],"action.":[29],"Aim:":[30],"The":[31,86,180],"purpose":[32],"of":[33,171,186,197],"present":[35,59],"study":[36,60],"was":[37,145],"formulate":[39],"evaluate":[41],"rivastigmine":[42,61,165],"loaded":[43,62,166],"chitosan":[44,167,187],"nanoparticles":[45,64,88,135,168,188],"for":[46,193],"sustained":[47,177,195],"release.":[48],"Methods:":[49],"Rivastigmine":[50],"is":[51],"a":[52,176,190],"short":[53],"acting":[54],"cholinesterase":[55],"inhibitors":[56],"(ChEI).":[57],"In":[58,159],"chitosan-tripolyphosphate":[63],"were":[65,89,114,136,169],"prepared":[66,87],"ionic":[68],"gelation":[69],"method":[70],"in":[71,110,138,175],"five":[72],"different":[73,118],"batches":[74],"with":[75],"variable":[76],"drug/polymer":[77],"ratios":[78,119],"(1:1,":[79],"1:2,":[80],"1:3,":[81],"1:5":[82],"1:7).":[84],"Results:":[85],"evaluated":[90],"scanning":[92,102],"electron":[93,97,130],"microscopy":[94,98,131],"(SEM),":[95],"transmission":[96],"(TEM)":[99],"differential":[101],"calorimetry":[103],"(DSC).":[104],"Further,":[105],"entrapment":[107,126],"efficiency":[108,127],"vitro":[111,160],"release":[112,161],"studies":[113,162],"carried":[115],"out.":[116],"Among":[117],"studied,":[120],"1:3":[121],"ratio":[122],"showed":[123,152,163,183],"highest":[124],"(83.74%).":[128],"Scanning":[129],"results":[132,182],"revealed":[133],"that":[134,164],"spherical":[137],"shape.":[139],"Particle":[140],"size":[141],"polydispersity":[143],"index":[144],"analyzed":[146],"photon":[148],"correlation":[149],"spectroscopy":[150],"average":[153],"258":[154],"nm":[155],"0.261":[157],"respectively.":[158],"capable":[170],"releasing":[172],"manner.":[178],"Conclusion:":[179],"experimental":[181],"suitability":[185],"as":[189],"potential":[191],"carrier":[192],"providing":[194],"rivastigmine.":[198]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-27T00:00:00"}